scispace - formally typeset
B

Bastian Keck

Researcher at University of Erlangen-Nuremberg

Publications -  84
Citations -  2816

Bastian Keck is an academic researcher from University of Erlangen-Nuremberg. The author has contributed to research in topics: Bladder cancer & Cystectomy. The author has an hindex of 24, co-authored 84 publications receiving 2249 citations. Previous affiliations of Bastian Keck include University of Southern California.

Papers
More filters
Journal ArticleDOI

Female sex is an independent risk factor for reduced overall survival in bladder cancer patients treated by transurethral resection and radio- or radiochemotherapy.

TL;DR: Female sex is an independent prognostic factor for reduced OS and CSS in bladder cancer patients treated by TURBT and RT or RCT, in agreement with those reported for OS after radical cystectomy in muscle-invasive bladder cancers.
Journal ArticleDOI

Diagnostic potential of major and trace elements in the serum of bladder cancer patients.

TL;DR: It is suggested that determination of the elements calcium, lithium, nickel and strontium in the serum could be a new and promising tool for the early diagnosis of BCa.
Journal ArticleDOI

Immunohistochemiocal subtyping using CK20 and CK5 can identify urothelial carcinomas of the upper urinary tract with a poor prognosis

TL;DR: Immunohistochemical subgrouping of upper tract urothelial carcinomas by analyzing CK5 and CK20 expression can be performed in a routine setting and can identify tumors with a significantly worse cancer-specific survival prognosis.
Journal ArticleDOI

Piwil 2 Expression Is Correlated with Disease-Specific and Progression-Free Survival of Chemotherapy-Treated Bladder Cancer Patients

TL;DR: A combination of weak cytoplasmic and absent nuclear expression of Piwil 2 is significantly associated with an increased risk of DSS and tumor progression, which indicates that PiWil 2 could be a valuable prognostic marker for high-risk BCa patients.